Risk‐stratified approach by <scp>aMAP</scp> score for community population infected with hepatitis B and C to guide subsequent liver cancer screening practice: A cohort study with 10‐year follow‐up
Hua He, Jing Jiang(Dalian Medical University), Yuchen Pan(China Pharmaceutical University), Xuerong Tao(Jilin University), Tianye Zhao(Nantong University), Yangyu Zhang(Fuzhou University), Yanhang Gao(Jilin University), Zhifang Jia(Jilin University), Changgui Kou(Jilin University), Jiaxin Yi(Jilin University), Hongqin Xu(Jilin University), Donghui Cao(Jilin University), Yuehui Wang(Jilin University), Haiyong Lv(Jilin University), Yanhua Wu(Jilin University), Junqi Niu(Jilin University)
Cited by 2
Related Papers
Prevalence of depressive disorders and treatment in China: a cross-sectional epidemiological study
|The Lancet Psychiatry|2021|826
aMAP risk score predicts hepatocellular carcinoma development in patients with chronic hepatitis
|Journal of Hepatology|2020|346